#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	147	4046	16S	1529	1529	100.0	16S.l6.c4.ctg.1	2542	474.4	1	SNP	n	C1184T	0	.	.	1184	1184	C	1703	1703	C	550	C,T	487,1	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	147	4046	16S	1529	1529	100.0	16S.l6.c4.ctg.1	2542	474.4	0	HET	.	.	.	C799T	.	799	799	C	1318	1318	C	589	C,T	387,115	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	6522	23S	2890	2890	99.86	23S.l15.c17.ctg.1	3899	502.1	0	.	n	.	0	T695C	SNP	695	695	T	1218	1218	C	482	C,T	414,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	6522	23S	2890	2890	99.86	23S.l15.c17.ctg.1	3899	502.1	0	.	n	.	0	G856C	SNP	856	856	G	1379	1379	C	484	C,G	420,2	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	6522	23S	2890	2890	99.86	23S.l15.c17.ctg.1	3899	502.1	0	.	n	.	0	G1337A	SNP	1337	1337	G	1860	1860	A	551	A	478	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	6522	23S	2890	2890	99.86	23S.l15.c17.ctg.1	3899	502.1	0	.	n	.	0	T1971C	SNP	1971	1971	T	2494	2494	C	663	C	569	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	6522	23S	2890	2890	99.86	23S.l15.c17.ctg.1	3899	502.1	1	SNP	n	A2045G	0	.	.	2045	2045	A	2568	2568	A	689	A	586	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	6522	23S	2890	2890	99.86	23S.l15.c17.ctg.1	3899	502.1	1	SNP	n	C2597T	0	.	.	2597	2597	C	3120	3120	C	649	C	557	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
folP.WHO_X_01360c	folP.WHO_X_01360c	1	1	539	502	folP	852	852	98.24	folP.l15.c4.ctg.1	1821	82.8	0	.	p	.	0	R7Q	NONSYN	19	21	CGG	501	503	CAG	85;84;84	C;A;G	75;75;74	.	.
folP.WHO_X_01360c	folP.WHO_X_01360c	1	1	539	502	folP	852	852	98.24	folP.l15.c4.ctg.1	1821	82.8	0	.	p	.	0	E12K	NONSYN	34	36	GAA	516	518	AAA	85;85;85	A;A;A	78;78;77	.	.
folP.WHO_X_01360c	folP.WHO_X_01360c	1	1	539	502	folP	852	852	98.24	folP.l15.c4.ctg.1	1821	82.8	0	.	p	.	0	F31L	NONSYN	91	93	TTT	573	575	TTG	92;92;92	T,G;T;G	78,1;79;78	.	.
folP.WHO_X_01360c	folP.WHO_X_01360c	1	1	539	502	folP	852	852	98.24	folP.l15.c4.ctg.1	1821	82.8	0	.	p	.	0	S68P	NONSYN	202	204	TCG	684	686	CCG	109;109;109	C;C;G	88;85;86	.	.
folP.WHO_X_01360c	folP.WHO_X_01360c	1	1	539	502	folP	852	852	98.24	folP.l15.c4.ctg.1	1821	82.8	0	.	p	.	0	F72Y	NONSYN	214	216	TTC	696	698	TAT	108;108;108	T;A;T	88;86;89	.	.
folP.WHO_X_01360c	folP.WHO_X_01360c	1	1	539	502	folP	852	852	98.24	folP.l15.c4.ctg.1	1821	82.8	0	.	p	.	0	P74S	NONSYN	220	222	CCG	702	704	TCG	107;109;109	T;C;G	87;89;89	.	.
folP.WHO_X_01360c	folP.WHO_X_01360c	1	1	539	502	folP	852	852	98.24	folP.l15.c4.ctg.1	1821	82.8	0	.	p	.	0	A89V	NONSYN	265	267	GCG	747	749	GTG	97;97;96	G;T;G	85;84;83	.	.
folP.WHO_X_01360c	folP.WHO_X_01360c	1	1	539	502	folP	852	852	98.24	folP.l15.c4.ctg.1	1821	82.8	0	.	p	.	0	E151K	NONSYN	451	453	GAA	933	935	AAA	114;114;116	A;A;A	102;103;100	.	.
folP.WHO_X_01360c	folP.WHO_X_01360c	1	1	539	502	folP	852	852	98.24	folP.l15.c4.ctg.1	1821	82.8	1	SNP	p	R228S	1	.	.	682	684	AGC	1164	1166	AGC	150;152;152	A;G;C	126;128;124	folP.WHO_X_01360c:1:1:R228S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	1422	gyrA	2751	2751	100.0	gyrA.l15.c4.ctg.1	3729	114.2	1	SNP	p	S91F	0	.	.	271	273	TCC	722	724	TCC	132;133;134	T;C;C	113;113;116	gyrA.WHO_F_00668c:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	1422	gyrA	2751	2751	100.0	gyrA.l15.c4.ctg.1	3729	114.2	1	SNP	p	D95G	0	.	.	283	285	GAC	734	736	GAC	136;135;136	G;A;C	114;115;118	gyrA.WHO_F_00668c:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	1422	gyrA	2751	2751	100.0	gyrA.l15.c4.ctg.1	3729	114.2	1	SNP	p	D95N	0	.	.	283	285	GAC	734	736	GAC	136;135;136	G;A;C	114;115;118	gyrA.WHO_F_00668c:1:1:D95N:gyrA.95N:Resistance to fluoroquinolones	.
mtrR.WHO_M_01390	mtrR.WHO_M_01390	1	1	27	504	mtrR	633	633	100.0	mtrR.l6.c17.ctg.1	1588	95.1	1	SNP	p	G45D	1	.	.	133	135	GAC	629	631	GAC	147;146;147	G;A,C;C	121;118,1;121	mtrR.WHO_M_01390:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	19	334	mtrR_promoter	250	250	100.0	mtrR_promoter.l15.c4.ctg.1	1280	78.4	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
parC.WHO_V_00204c	parC.WHO_V_00204c	1	1	27	1404	parC	2304	2304	99.83	parC.l6.c4.ctg.1	3167	132.7	1	SNP	p	D86N	0	.	.	256	258	GAC	653	655	GAC	158;158;158	G;A;C	140;138;140	parC.WHO_V_00204c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_V_00204c	parC.WHO_V_00204c	1	1	27	1404	parC	2304	2304	99.83	parC.l6.c4.ctg.1	3167	132.7	1	SNP	p	S88P	0	.	.	262	264	TCC	659	661	TCC	157;157;157	T;C;C	138;140;140	parC.WHO_V_00204c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	1194	parE	1986	1986	100.0	parE.l15.c4.ctg.1	3023	118.5	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1732	1734	GGC	151;150;149	G;G;C	137;132;132	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.15.002	penA.15.002	1	1	27	1050	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2702	116.5	1	SNP	p	A311V	0	.	.	931	933	GCA	1393	1395	GCA	138;139;139	G;C,G;A	121;120,1;121	penA.15.002:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.15.002	penA.15.002	1	1	27	1050	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2702	116.5	1	SNP	p	I312M	0	.	.	934	936	ATC	1396	1398	ATC	140;140;142	A;T;C	123;120;123	penA.15.002:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.15.002	penA.15.002	1	1	27	1050	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2702	116.5	1	SNP	p	V316T	0	.	.	946	948	GTG	1408	1410	GTG	142;144;144	G;T;G	126;129;128	penA.15.002:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.15.002	penA.15.002	1	1	27	1050	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2702	116.5	1	SNP	p	V316P	0	.	.	946	948	GTG	1408	1410	GTG	142;144;144	G;T;G	126;129;128	penA.15.002:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.15.002	penA.15.002	1	1	27	1050	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2702	116.5	1	SNP	p	T483S	0	.	.	1447	1449	ACC	1909	1911	ACC	140;140;140	A;C;C	123;121;120	penA.15.002:1:1:T483S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.15.002	penA.15.002	1	1	27	1050	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2702	116.5	1	SNP	p	A501P	0	.	.	1501	1503	GCG	1963	1965	GCG	135;136;137	G;C;G	117;104;113	penA.15.002:1:1:A501P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.15.002	penA.15.002	1	1	27	1050	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2702	116.5	1	SNP	p	A501V	0	.	.	1501	1503	GCG	1963	1965	GCG	135;136;137	G;C;G	117;104;113	penA.15.002:1:1:A501V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.15.002	penA.15.002	1	1	27	1050	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2702	116.5	1	SNP	p	G542S	0	.	.	1624	1626	GGC	2086	2088	GGC	123;122;123	G;G;C	106;112;109	penA.15.002:1:1:G542S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.15.002	penA.15.002	1	1	27	1050	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2702	116.5	1	SNP	p	G545S	0	.	.	1633	1635	GGC	2095	2097	GGC	122;123;123	G,T;G;C	107,1;110;109	penA.15.002:1:1:G545S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.15.002	penA.15.002	1	1	27	1050	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2702	116.5	1	SNP	p	P551S	0	.	.	1651	1653	CCG	2113	2115	CCG	125;126;125	C;C;G,C	102;110;105,1	penA.15.002:1:1:P551S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	1352	ponA	2397	2397	99.96	ponA.l15.c17.ctg.1	3444	117.9	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1797	1799	CCG	122;122;124	C;C,T;G	101;103,1;107	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	776	porA	1146	1146	99.83	porA.l15.c4.ctg.1	2148	108.4	0	.	p	.	0	S22G	NONSYN	64	66	AGC	527	529	GGC	135;135;134	G;G;C,T	115;110;113,1	.	.
porA.NCCP11945	porA.NCCP11945	1	0	531	776	porA	1146	1146	99.83	porA.l15.c4.ctg.1	2148	108.4	0	.	p	.	0	M83fs	FSHIFT	247	247	A	709	709	C	138	C	126	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	734	porB1b	1035	1035	99.04	porB1b.l6.c4.ctg.1	2269	93.8	0	.	p	.	0	.	INDELS	629	630	AA	1128	1130	TAG	157;159;160	T;A;G	136;141;139	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	734	porB1b	1035	1035	99.04	porB1b.l6.c4.ctg.1	2269	93.8	0	.	p	.	0	.	MULTIPLE	631	633	TAC	1132	1135	CAAT	160;160;162;163	C;A;A;T	139;138;141;142	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	734	porB1b	1035	1035	99.04	porB1b.l6.c4.ctg.1	2269	93.8	0	.	p	.	0	N212fs	FSHIFT	634	634	A	1137	1137	T	161	T	143	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	734	porB1b	1035	1035	99.04	porB1b.l6.c4.ctg.1	2269	93.8	1	SNP	p	G120K	0	.	.	358	360	GGT	856	858	GGT	136;136;138	G,T;G;T,C	116,1;118;117,2	porB1b.WHO_U_02278c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	734	porB1b	1035	1035	99.04	porB1b.l6.c4.ctg.1	2269	93.8	1	SNP	p	A121D	0	.	.	361	363	GCC	859	861	GCC	139;139;138	G,A;C;C	116,1;119;117	porB1b.WHO_U_02278c:1:1:A121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	734	porB1b	1035	1035	99.04	porB1b.l6.c4.ctg.1	2269	93.8	1	SNP	p	A121N	0	.	.	361	363	GCC	859	861	GCC	139;139;138	G,A;C;C	116,1;119;117	porB1b.WHO_U_02278c:1:1:A121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	2510	rpoB	4179	4179	99.98	rpoB.l15.c4.ctg.1	5198	144.9	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	362	rpsJ	312	312	100.0	rpsJ.l6.c4.ctg.1	1316	82.6	1	SNP	p	V57M	1	.	.	169	171	ATG	700	702	ATG	145;144;147	A;T,C;G	128;125,1;129	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
